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Abstract
Rationale: Immunoglobulin (Ig)G4-related pseudotumors of the liver are very rare diseases that are difﬁcult to distinguish from
malignant tumors. They can be usually improved by steroid therapy. Actinomycosis is a chronic, suppurative, granulomatous
infection, for which immune suppression is a predisposing factor. It can also mimic malignant tumors.
Patientconcerns:A 67-year-old man presented with mild abdominal discomfort and a 5-kg weight loss for 3 months. Initially, he
visited another hospital and was treated with antibiotics under the assumption of a liver abscess. Symptom was not resolved.
Diagnoses:He diagnosed as having an IgG4-related pseudotumor of the right lobe of the liver after liver biopsy. Despite 2 months
of steroid therapy, the liver mass was aggravated and invaded the right lung, as observed on follow-up computed tomography scan.
Interventions: We performed en bloc resection of the tumor under the assumption that it was a malignant tumor.
Outcomes: The pathology of the tumor was revealed as actinomycotic colonies and IgG4-positive plasma cells of the liver. He
recovered well and was discharged with ursodeoxycholic acid tablet for 14 days. After 3 months, he underwent postoperative follow-
up CT and there was no remarkable ﬁnding in remnant left hepatic lobe.
Lessons: Hepatic actinomycosis and IgG4-related pseudotumors of the liver are both difﬁcult to diagnose. As in our patient,
combined diseases are more difﬁcult to diagnose and to determine the optimal treatment. Since immunosuppression therapy of
autoimmune diseases can cause and aggravate infection, management must be approached carefully. We can learn that various
possibilities must be considered before diagnosing and treating a hepatic mass.
Abbreviations: CT = computed tomography, Ig = immunoglobulin.
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1. Introduction Histological conﬁrmation and an accurate diagnosis are impor-Since IgG4-related disease was identiﬁed initially in 2003, it is
well known that disease can be involved in various sites of the
body, for example, the pancreas, biliary tree, liver, kidneys,
salivary gland, breast, pericardium, skin, lungs, meninges, and
pituitary gland.
IgG4-related diseases that involve the liver appear in the form
of sclerosing cholangitis or an inﬂammatory pseudotumor.Editor: N/A.
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1tant to avoid unnecessary treatment, such as surgical resection, in
patients with IgG4-related hepatopathy.[1–3]
Actinomycosis, primarily from Actinomyces, is a chronic,
suppurative, granulomatous infection.[4–7] It can occur in various
anatomical sites such as the face, bone and joint, gastrointestinal
tract, urogenital tract, and central nerve system. Among them,
hepatic actinomycosis is rare. It accounts for 15% of abdominal
actinomycosis and 5% of all actinomycosis. Hepatic actinomy-
cosis is easily misdiagnosed as a malignant tumor because it
manifests nonspeciﬁc symptoms, and it is similar to a tumor
radiologically.
IgG4-related hepatitis and hepatic actinomycosis are not easily
distinguished from malignant tumors. Both diseases are rare and
require different treatments. We describe a patient in whom
IgG4-related hepatitis and liver actinomycosis were diagnosed
simultaneously.
2. Case report
A67-year-oldman presentedwithmild abdominal discomfort and
a 5-kg weight loss for 3 months. He was on medication because of
diabetesmellitus for 4 years and hypertension for 6 years. Initially,
he visited another hospital and was treated with antibiotics (type
unknown) under the assumptionof a liver abscess.However, as the
symptom was not resolved, he was transferred to our hospital’s
Internal Medicine Department. Radiologic and hematological
evaluations were performed to make a differential diagnosis.
During the radiologic evaluation, the computed tomography (CT)
scan showed an 8.57.8-cm ill-deﬁned, suspicious, delayed
Figure 1. Computed tomography scan showing an 8.57.8-cm ill-deﬁned
suspicious, delayed enhancing, lobulated mass-like lesion in the right hepatic
lobe with hyperemic change of adjacent hepatic parenchyma and segmental
portal vein obliteration. The ﬁrst impression was an inﬂammatory condition such
as an inﬂammatory pseudotumor.
Figure 2. Magnetic resonance imaging scan (MRI) showing a 9.38.3-cm ill-
deﬁned suspicious, delayed enhancing, lobulated mass-like lesion in the right
hepatic lobe. Lesions show hypo-signal intensities in T1 and hyper-signal
intensities in T2. The diagnosis based on MRI scan ﬁndings was the same as
that based on the computed tomography scan ﬁndings. MRI=magnetic
resonance imaging.
Figure 3. Positron emission tomography-computed tomography scan
showing a 6.8-cm lobulated mass with strong ﬂuoro-2-deoxy-D-glucose
uptake in segments 6 and 7 of the liver.
Figure 4. Compared to the previous computed tomography scan, the hepatic
inﬂammatory pseudotumor in the posterior segment is aggravated (97cm). It
has an unusual feature of sarcomatous transformation.
Figure 5. (A) Photograph showing the status of hilar dissection. (B) After
performing right lobectomy of the liver, we repaired the diaphragmwith a patch.
The photograph shows the diaphragm after repair.
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Lee et al. Medicine (2018) 97:24 www.md-journal.comenhancing lobulated mass in the right hepatic lobe. It seemed to be
an inﬂammatory pseudotumor (Fig. 1).On themagnetic resonance
imaging, a 9.38.3-cm ill-deﬁned, suspicious, delayed enhancing
lobulated mass was identiﬁed (Fig. 2). The positron emission
tomography-CT scan on December, 2016 showed a lobulated
mass about6.8cmwith strongﬂuoro-2-deoxy-D-glucoseuptake in
segments 6 and7of the liver and small hypermetabolic nodes in theFigure 6. (A) Liver gross picture, (B) Liver. (C) At a low magniﬁcation, sclerosing ﬁb
40). (D) At a lowmagniﬁcation, colonies ofActinomyces are seen (HE,40). (E) On
(HE, 100). (F) On high power ﬁeld, dense lymphoplasmacytic inﬁltration with st
3portocaval and aortocaval areas at the celiac axis level (Fig. 3).
After the liver biopsy, we found that the mass was present with an
abscess in the background of parenchymal ﬁbrosis with increased
IgG4-positive lymph plasma cells (about 30 IgG4-positive cells per
high power ﬁeld) (December, 2016) Thus, he received steroid
therapy for 3 months according to the treatment guideline. When
steroid therapy ended, he underwent follow-up CT. The CT scanrosis destroying the liver parenchyma is seen (hematoxylin and eosin stain [HE],
medium power ﬁeld, dense lymphoplasmacytic inﬁltration with ﬁbrosis is shown
oriform ﬁbrosis with patchy distribution is revealed (HE, 200).
Lee et al. Medicine (2018) 97:24 Medicineshowed that the liver mass was aggravated and increased in size
from 86cm to 97cm, and it invaded the right lower lung. It
had an unusual feature of sarcomatous transformation (Fig. 4).
The patient was referred for operation, so we performed en bloc
resection (lobectomyof the liver,wedge resection of the right lower
lobe, excision of the diaphragmatic tumor, and lymph node
dissection) (Fig. 5A and B). The ﬁnal pathologic report showed
dense lymphoplasmacytic inﬁltration with ﬁbrosis and abscess
formation, and actinomycotic colonies in hepatic and lung
parenchyma. It also showed many IgG4-positive plasma cells
(Fig. 6A and B). He recovered well and was discharged on May,
2017with ursodeoxycholic acid tablet for 14days.After 3months,
he underwent postoperative follow-up CT and there was no
remarkable ﬁnding in remnant left hepatic lobe.
3. Discussion
We describe the ﬁrst case of simultaneous IgG4-related
hepatopathy and hepatic actinomycosis. IgG4-related disease is
a systemic ﬁbroinﬂammatory condition that affects multiple
organs.[8] A histologic examination is essential for diagnosing
IgG4-related disease. Diagnostic criterion for IgG4-related
hepatopathy is the presence of more than 10 IgG4-positive
plasma cells per high power ﬁeld on liver biopsy or an IgG4:IgG
ratio is >40%.[9] Generally, IgG4-related disease can be treated
by steroid therapy. The recommended dose of prednisone is 30 to
40mg daily for 4 weeks before reducing it by 5mg every 2 weeks.
Two-thirds of patients showed radiological or clinical improve-
ment within 4 weeks after steroid therapy. Patients with relapse
or slow resolution can be treated with second-line immunosup-
pressive therapy.[1,8] Surgical resection is only recommended in
patients with an uncertain biopsy result, suspicious malignant
lesion, combined other pathology, and lack of response to
conservative management.
There have been a few reports of the relationship between
IgG4-related disease and malignancy. Ahn et al[10] reported that
the overall incidence of malignancy in patients with IgG4-related
disease was 23 times higher than that in the general population.
Wallace et al. reported that the prevalence of malignancy was 2.5
times higher than expected compared to the Surveillance,
Epidemiology, and End Results database.[11] Among all reports,
2 studies reported that lymphoma was the most common type ofTable 1











Jin et al (1) 1979 F 57 Y Unknown Unknown Gastric discom
Ryu et al (6) 1992 M 32 Y Y Y N
Lee et al (5) 1993 M 24 Y Y Y N
Kim et al (3) 2002 F 63 Y Y Unknown N
Park et al (7) 2008 F 78 Y Y N N
Ha et al (2) 2015 M 57 N N N N
Kong (4) 2016 M 24 N Y Y N
F= female, M=male, N=no, RUQ= right upper quadrant, Y= yes.
1. Chin SJ, Lee CK, Kim CW, et al. Actinomycosis of liver and greater omentum: a case report. Korea
2. Ha YJ, An JH, Shim JH, et al. A case of primary hepatic actinomycosis: an enigmatic inﬂammatory
3. Jun Uh K, Hyo Jin P, Young Goo S et al. Case Reports: A case of primary hepatic actinomycosis co
4. Kong EJ. Primary hepatic actinomycosis mimicking hepatic malignancy with metastatic lymph nodes
5. Lee JD, Kim PG, Jo HJ, et al. A case of primary hepatic actinomycosis. Journal of Korean Medical
6. Ryu JC, Lim CY, Yang ES, et al. A case of primary hepatic actinomycosis. The Korean Journal of G
7. Sang Jun Park, Chang Goo Lee, Sang Eok Kim, et al. A case of liver abscess associated with duod
4malignancy after or before the diagnosis of IgG4-related
disease.[11,12]
Etiologies of hepatic actinomycosis are thought to arise directly
or hepatogenically through the portal vein. Previous abdominal
operation, diabetes, oral disease, immunosuppression, and the
use of an intrauterine device are well-known causes of hepatic
actinomycosis. The clinical feature of hepatic actinomycosis is a
nonspeciﬁc symptom, such as fever, weight loss, and sometimes
abdominal pain. A single lesion with slow growing, low-density,
mass-like nodular change is the most common feature during a
radiologic evaluation. Hepatic actinomycosis mainly involves the
right lobe. This clinical feature and radiologic ﬁnding mimics a
malignant tumor. Pathologically, sulfur granule is a speciﬁc
ﬁnding. It is comprised of small lobulated microcolonies around
lymphocytes, plasma cells, epitheloid cells, and histiocytes of an
abscess.[13] Cultured and conﬁrmed Actinomyces is the most
accurate way to make a diagnosis, but overgrowth of an
associated microorganism, an inadequate incubation period, and
media make sulfur granule an alternative diagnostic ﬁnding. The
16s ribosomal ribonucleic acid gene sequence analysis will
become the precise method for making a diagnosis in the near
future.[14]
Since many antibiotics are acceptable for treating actinomy-
cosis, a surgical approach is not the ﬁrst choice of treatment.
Generally, the recommended treatment protocol for actinomy-
cosis is about 10 to 20 million units of intravenous penicillin via
injection and approximately 6 to 12 months of oral penicillin or
amoxicillin.[7,13,15–17] There were 7 cases of published hepatic
actinomycosis among Korean patients. Each patient had similar
symptoms and was treated with antibiotics (Table 1).[4,5,13,18–21]
Our patient received antibiotics at a previous hospital, but
we cannot ﬁnd any record about the kind of antibiotics
administered.
The case of our patient with sarcomatous intrahepatic
cholangiocarcinoma was presented at a hepatobiliary multidisci-
plinary conference. We discussed the possibility of many other
diseases. Surgical resection was ultimately recommended because
of rapid tumor growth and the invasive morphology. Postopera-
tively, the pathologist speculated that the actinomycosis of the
lungs invaded the liver parenchyma directly with IgG4-related
hepatopathy through the diaphragm. This made it difﬁcult to





fort Unknown Unknown Tetracycline 40 days
Percutaneous N Penicillin G 33 days
Percutaneous N Penicillin G 30 days
Percutaneous Unknown Unknown Unknown
Percutaneous N Penicillin G 20 days
Diagnostic laparoscopy Biopsy Penicillin G Ceftriaxone 60 days
Unknown Unknown Unknown Unknown
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Lee et al. Medicine (2018) 97:24 www.md-journal.comIn conclusion, IgG4-related hepatopathy and hepatic actino-
mycosis are difﬁcult to diagnose during the initial evaluation. In
our patient, determining proper treatment was more difﬁcult
because of the combined diseases. A multifaceted approach, such
as from the pathological and microbiological aspects, is needed
when determining the treatment method. Various possibilities
must be considered before diagnosing and treating IgG4-related
hepatopathy.4. Patient perspective
He did not have any problem when he came to our outpatient
clinic after discharge. He relieved symptoms like abdominal pain,
discomfort.Author contributions
Resources: Ji Sub Kim, Dong Ki Lee.
Supervision: Jin Hong Lim.
Writing – original draft: Joo Hyung Lee.
Writing – review & editing: Hyung Sun Kim, Jin Hong Lim.References
[1] Joshi D, Webster GJ. Biliary and hepatic involvement in IgG4-related
disease. Aliment Pharmacol Ther 2014;40:1251–61.
[2] Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological
entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:
982–4.
[3] Okazaki K, Uchida K, Koyabu M, et al. Recent advances in the concept
and diagnosis of autoimmune pancreatitis and IgG4-related disease. J
Gastroenterol 2011;46:277–88.
[4] Ha YJ, An JH, Shim JH, et al. A case of primary hepatic actinomycosis:
an enigmatic inﬂammatory lesion of the liver. Clin Mol Hepatol
2015;21:80–4.5with metastatic lymph Nodes by F-18 FDG PET/CT. Nucl Med Mol
Imaging 2016;50:93–4.
[6] Sharma M, Briski LE, Khatib R. Hepatic actinomycosis: an overview of
salient features and outcome of therapy. Scand J Infect Dis 2002;34:386–91.
[7] Yang XX, Lin JM, XuKJ, et al. Hepatic actinomycosis: report of one case
and analysis of 32 previously reported cases. World J Gastroenterol
2014;20:16372–6.
[8] Chen JH, Deshpande V. IgG4-related disease and the liver. Gastroenterol
Clin North Am 2017;46:195–216.
[9] Culver EL, Chapman RW. IgG4-related hepatobiliary disease: an
overview. Nat Rev Gastroenterol Hepatol 2016;13:601–12.
[10] Ahn SS, Song JJ, Park YB, et al. Malignancies in Korean patients with
immunoglobulin G4-related disease. Int J Rheum Dis 2017;20:1028–35.
[11] Wallace ZS, Wallace CJ, Lu N, et al. Association of IgG4-related disease
with history of malignancy. Arthritis Rheumatol 2016;68:2283–9.
[12] Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related
disease. Clin Exp Immunol 2015;181:191–206.
[13] Lee JD, Kim PG, Jo HJ, et al. A case of primary hepatic actinomycosis. J
Korean Med Sci 1993;8:385–9.
[14] Hansen JM, Fjeldsoe-Nielsen H, Sulim S, et al. Actinomyces species: a
Danish survey on human infections and microbiological characteristics.
Open Microbiol J 2009;3:113–20.
[15] Christodoulou N, Papadakis I, Velegrakis M. Actinomycotic liver
abscess. Case report and review of the literature. Chir Ital 2004;56:141–6.
[16] Kocabay G, Cagatay A, Eraksoy H, et al. A case of isolated hepatic
actinomycosis causing right pulmonary empyema. Chin Med J (Engl)
2006;119:1133–5.
[17] Lall T, Shehab TM, Valenstein P. Isolated hepatic actinomycosis: a case
report. J Med Case Rep 2010;4:45.
[18] Chin SJ, Lee CK, Kim CW, et al. Actinomycosis of liver and greater
omentum: a case report. Korean J Pathol 1979;13:303–8.
[19] Jun UhK, Hyo Jin P, Young Goo S, et al. Case Reports: A case of primary
hepatic actinomycosis coinfected with a-streptococcus. Korean J Med
2002;63:596–600.
[20] Ryu JC, LimCY, Yang ES, et al. A case of primary hepatic actinomycosis.
Korean J Gastroenterol 1992;24:388–93.
[21] Sang Jun Park, Chang Goo Lee, Sang Eok Kim, et al. A case of liver
abscess associated with duodenal perforation by a toothpick. Clin
Endosc 2008;36:390–4.
